Central nervous system efficacy of furmonertinib (AST2818) in patients with EGFR T790M mutated non-small cell lung cancer: a pooled analysis from two phase 2 studies

Overview of attention for article published in BMC Medicine, April 2023

Altmetric Badge

About this Attention Score

Average Attention Score compared to outputs of the same age

Mentioned by

twitter: 2 X users

reddit: 1 Redditor

Citations

dimensions_citation: 5 Dimensions

Readers on

mendeley: 9 Mendeley

Summary X Reddit Dimensions citations

So far, Altmetric has seen 2 X posts from 2 X users, with an upper bound of 9,498 followers.

🙏🪷❤️ Central nervous system efficacy of furmonertinib (AST2818) in patients with EGFR T790M mutated non-small cell lung … https://t.co/igAumqkUjz

07 Jul 2023

Reply Repost Favourite

Xingsheng Hu, Shucai Zhang, Zhiyong Ma and colleagues assessed the efficacy of Furmonertinib on the CNS of individuals living with EGFR T790M mutated non-small cell lung cancer. Read the full study here: https://t.co/N9vamUulll https://t.co/nrDoyfbO4J

02 May 2023

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.